Inhibitory effect of compound Liuyueqing on synthesis of collagen type I in hepatic stellate cells

Chinese Journal of New Drugs

Volumn 20, Issue 6, 2011, Pages

  Zhang, Shi Jun ^a   Chen, Zhao Ni ^a   Zhang, Zhi Wei ^b   Li, Yong Wen ^a   Lin, Xing ^a   Huang, Ren Bin ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b GUANGXI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Collagen type I (Col I); Compound Liuyueqing (CLYQ); Hepatic fibrosis; Hepatic stellate cell (HSC)

Indexed keywords

CHINESE DRUG; COLLAGEN TYPE 1; LIUYUEQING; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; COLLAGEN SYNTHESIS; CONCENTRATION RESPONSE; DOWN REGULATION; DRUG EFFECT; EXTRACELLULAR MATRIX; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIVER FIBROSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STELLATE CELL;

EID: 84863337976     PISSN: 10033734     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. 2005, 28(7):541-543.
2. 2007, 30(2):191-193.
3. 2007, 23(1): 59-61.
4. VOGEL S, PIANTEDOSI R, FRANK J, et al. An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro[J]. J Lipid Res, 2000, 41 (6):882-893.
5. 2005, 16(1):16-19.
6. MOSMANN T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays [J]. J Immunol Methods, 1983, 65(1-2):55-63.
7. 1990: 143-146.
8. HUI A Y, FRIEDMAN S L. Molecular basis of hepatic fibrosis [J]. Expert Rev Mol Med, 2003, 5(5):1-23.
9. MURPHY F, ARTHUR M, IREDALE J. Developing strategies for liver fibrosis treatment [J]. Expert Opin Investig Drugs, 2002, 11 (11):1575-1585.